batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. ESMO 2023 – regulators come under fire for Retevmo trial requirements 23 October 2023 ESMO 2023 – Biontech’s Neon buy fails to shine 23 October 2023 ESMO 2023 – Merck makes its KRAS entrance 22 October 2023 ESMO 2023 – Daiichi shows why Merck paid $1.5bn for CDH6 22 October 2023 ESMO 2023 – the colorectal KRAS pipeline swells again 22 October 2023 Bristol nips at Roche’s heels in the subcutaneous PD-1 race 20 October 2023 ESMO 2023 – Amgen keeps tarlatamab filing plans under wraps 20 October 2023 ESMO 2023 – Roche heralds "unprecedented" Alecensa data 18 October 2023 Load More